Evidence map›Paper›PMID 36288015›Full record

ArticleTropical medicine and infectious disease2022

Molecular Characterization and Antifungal Susceptibility of

Ehssan Moglad, Samar Saeed, Humodi Saeed, Hind Ahmed, Kwathar Salih, Hisham Altayb, Wafa Elhag

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  2. Article
  3. Article
  4. Antifungal Susceptibility and Genotypic Analysis ofInfection and drug resistance · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Ehssan MogladDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj P.O. Box 173, Saudi Arabia.
Samar SaeedDepartment of Microbiology, Faculty of Medical Laboratory Sciences, Sudan University of Science and Technology, Khartoum P.O. Box 407, Sudan.
Humodi SaeedDepartment of Microbiology, Faculty of Medical Laboratory Sciences, Sudan University of Science and Technology, Khartoum P.O. Box 407, Sudan.
Hind AhmedDepartment of Microbiology, Faculty of Medical Laboratory Sciences, Sudan University of Science and Technology, Khartoum P.O. Box 407, Sudan.ORCID 0000-0001-7747-515X
Kwathar SalihDepartment of Microbiology, Faculty of Medical Laboratory Sciences, Sudan University of Science and Technology, Khartoum P.O. Box 407, Sudan.
Hisham AltaybDepartment of Biochemistry, Faculty of Science, King Abdulaziz University, Building A 90, Jeddah P.O. Box. 80200, Saudi Arabia.ORCID 0000-0002-2635-9383
Wafa ElhagDepartment of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha P.O. Box 1290, Saudi Arabia.
Sudan University of Science and Technology · SDAl-Neelain University · SDKing Abdulaziz University · SAPrince Sattam Bin Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary aspergillosis is a lung infection caused by

methodThree hundred and eighty-four sputum or bronchoalveolar lavage samples were collected and processed for the isolation and identification, and characterization of

resultThe overall results revealed that out of 384 patients, 32 (8.3%) were positive for fungal growth, including 28 (87.5%)

conclusionsThe prevalence of aspergillosis was high, with a significant association with underlying lung diseases. Voriconazole was the drug of choice for isolated fungi.

Indexed as

antifungalchronic pulmonary infectionKhartoum-SudanPCRpulmonary aspergillosis

Identifiers

PMID36288015
PMCPMC9612272
OpenAlexW4298003388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.